Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_assertion type Assertion NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_head.
- NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_assertion description "[Mutation is not common in TR genes, whereas hypermethylation of the TRbeta gene as an alternative gene silencing mechanism is highly prevalent in thyroid cancer, particularly FTC, consistent with a possible tumor suppressor role of this gene for FTC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_provenance.
- NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_assertion evidence source_evidence_literature NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_provenance.
- NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_assertion SIO_000772 17911173 NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_provenance.
- NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_assertion wasDerivedFrom befree-20150227 NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_provenance.
- NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_assertion wasGeneratedBy ECO_0000203 NP876869.RAZR-Ohe1z1Atx1CfmJHXRnD2Bx-wyIlz4abrJk6WJBVU130_provenance.